These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9212851)
1. Cutaneous toxicity following the administration of dactinomycin. Coppes MJ; Jorgenson K; Arlette JP Med Pediatr Oncol; 1997 Sep; 29(3):226-7. PubMed ID: 9212851 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous toxicity following administration of dactinomycin. Van Gool SW; van den Oord J; Uyttebroeck A; Brock P Med Pediatr Oncol; 1998 Aug; 31(2):128. PubMed ID: 9680944 [No Abstract] [Full Text] [Related]
4. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity. Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793 [TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Ludwig R; Weirich A; Abel U; Hofmann W; Graf N; Tournade MF Med Pediatr Oncol; 1999 Nov; 33(5):462-9. PubMed ID: 10531570 [TBL] [Abstract][Full Text] [Related]
6. Mometasone furoate versus betamethasone vale-rate in the treatment of allergic contact dermatitis. Grandolfo M; Vena GA; Angelini G; Bianchi B J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):178-80. PubMed ID: 10343953 [No Abstract] [Full Text] [Related]
7. Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy. Lebwohl M; Peets E; Chen V Int J Dermatol; 1993 Nov; 32(11):830-1. PubMed ID: 8270349 [No Abstract] [Full Text] [Related]